1.Zajtchuk, R, Bellamy, RF: Medical aspects of chemical and biological warfare Textbook of Military Medicine. Walter Reed Army Medical Center: Washington DC, USA: The Office of the Surgeon General at TTM Publications, Bordon Institute, 1997.
2.Terrill, WA: The chemical warfare legacy of the Yemen war. Comparative Strategy 1991; 10(2): 109–119.
3.Waters, L: Chemical weapons in the Iran/Iraq War. Military Review 1990; 70(10): 57–63.
4.US Department of State: Chemical Warfare in Southeast Asia and Afghanistan. Report to the Congress from Secretary of State Alexander Haig, Jr, Special Report No 98 (Washington, D.C.US Department of State), 1982.
5.Human Rights Watch: Chemical warfare in Bosnia? The strange experiences of Srebrenica survivors. Human Rights Watch 1998; 10: 9(D).
6. United Nations Security Council Resolution 687, 1991.
7.United Nations: The United Nations and the Iraq-Kuwait Conflict, 1990–1996. The United Nations Blue Book Series, Volume IX, United Nations: New York, USA, Department of public information, 1996.
8.Aas, P: UNSCOM's and IAEA's disarmament of Iraq's weapons of mass destruction. International Politikk 1997; 55(1): 41–60.
9.Pearson, G: The UNSCOM Saga: Chemical and Biological Weapons Non-Proliferation. London, England: MacMillan Press Ltd., 1999.
10.Lia, B, Hegghammer, T, Andersen, RIV, Kjøk, Å, Bokhari, L: Nuclear materials, gas and microbes as terrorist weapons? Groups interest in, and actual use of non-conventional weapons. FFI/Rapport 2001; 29–30.
11.Morita, H, Yanagisawa, N, Nakajima, T, Shimizu, M, Hirabayashi, H, Okudera, H, Nohara, M, Midorikawa, Y, Mimura, S: Sarin poisoning in Matsumoto, Japan. Lancet 1995; 346: 290–293.
12.Otomi, S, Takase, M, Kumagai, F: Sarin poisoning in Japan: A clinical experience in Japan Self Defence Force (JSDF) Central Hospital. Int Review of Armed Forces Medical Services 1996; 4–6: 97–102.
13.Okudera, H, Morita, H, Iwashita, T, Shibata, T, Odagir, T, Kobayashi, S, Yanagisawa, N: Unexpected nerve gas exposure in the city of Matsumoto: Report of rescue activity in the first sarin gas terrorism. Am J Emerg Med 1997; 15(5) 527–528.
14.Mirzayanov, V, Fedorov, L: A poisoned policy, Moscow News 1992; 27 September -04 October:9.
15.Stock, T: Chemical and biological weapons: Developments and proliferation. SIPRI Yearbook 1993: World Armaments and Disarmaments, Oxford, UK: Oxford University Press, 1993; 7: 259–292.
16.Stock, T, De Geer, A: Chemical weapons developments. SIPRI Yearbook 1994, Oxford, UK: Oxford University Press, 1994. pp 9:315–342.
17.Mirzaynov, S: Dismantling the Soviet/Russian chemical weapons complex: An insider's view. In: Chemical Weapons Disarmanent in Russia: Problems and Prospectis. Report No. 17, October 1995, the Henry L. Stimson Center. Eds: Smithson, AE, Mirzayanov, S, Lajoie, R, Krepon, M.
18.Leadbeater, L, Inns, RH, Rylands, JM: Treatment of poisoning by soman. Fund App Toxicol 1985; 5: S225–S231.
19.Friedman, A, Kaufner, D, Shemer, J, Hendler, I, Soreq, H, Tur-Kaspa, I: Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Medicine 1996; 2: 1382–1385.
20.Taylor, P: Anticholinesterase agents. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed.Hardman, JG, Limbird, LE, Molinoff, PB, Ruddon, RW, Gilman, AG (eds), New York, NY: McGraw-Hill, 1996. pp 161–176.
21.McDonough, JH, Shih, T-M: Pharmacological modulation of soman-induced seizures, Neurosci Biobehav Rev 1993; 17: 203–215.
22.Lallement, G, Dorandeu, F, Filliat, P, Carpentier, P, Baille, V, Blanchet, G: Medical management of organophosphate-induced seizures. J Physiol (Paris) 1998; 92: 369–373.
23.McDonough, JH, Zoeffel, LD, McMonagle, J, Copeland, TL, Smith, CD, Shih, TM: Anticonvulsant treatment of nerve agent seizures: Anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 2000; 38: 1–14.
24.Anderson, DR, Harris, LW, Chang, FT, Baze, WB, Capacio, BR, Byers, SL, Lennox, WJ: Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine. Drug Chem Toxico. 1997; 20: 115–131.
25.Shih, T-M, McDonough, JH, Koplovitz, I: Evaluation of anticonvulsant drugs for soman-induced seizure activity. J Am Coll Toxicol 1997; 15: 2: S43–S60.
26.Sidell, FR: Nerve agents. In: Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Zajtchuk, R, Bellamy, RF (eds), Walter Reed Army Medical Center, Washington DC, USA: The Office of The Surgeon General at TTM Publications, Bordon Institute, 1997. pp 129–179.
27.Dawson, RM: Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994; 14: 5: 317–331.
28.Lundy, PM, Hand, BT, Broxup, BR, Yipchuk, G, Hamilton, MG: Distribution of the bispyridinium oxime (14C)HI-6 in male and female rats. Arch To xicol 1990; 64: 377–382.
29.Clement, JG: Central activity of acetylcholinesterase oxime reactivators. Appl Pharmacol Toxicol 1992; 112: 104–109.
30.Cassel, G, Fosbraey, P: Measurement of oxime HI-6 after peripheral administration in tandem with neurotransmitter levels in striatal dialysates: Effects of soman intoxication. J Pharmacol Toxicol Methods 1996; 35: 159–166.
31.Cassel, G, Karlsson, L, Waara, L, Ang, KW, Göransson-Nyberg, A: Pharmacokinetics and effects of HI-6 in blood and brain of soman-intoxi-cated rats: A microdialysis study. Eur J Pharmacol 1997; 332: 43–52.
32.McDonough, JH, McMonagle, J, Copeland, T, Zoeffel, D, Shih, FM: Comparative evaluation of bezodiazepines for control of soman-induced seizures. Arch To xicol 1999; 73: 473–478.
33.Wolthuis, OL, van Helden, HPM, Melchers, BPC, Busker, RW, de Groot, DMG: Search for a therapy against soman-intoxication. Neurosci Behav Reviews 1994; 18: 4: 469–486.
34.Harris, LW, McDonough, JH, Sticher, DL, Lennox, WJ: Protection against both lethal and behavioural effects of soman. Drug Chem Toxicol 1984; 7: 605–624.
35.Solana, RP, Gennings, C, Carter, WH, Anderson, D, Lennox, WJ, Carchman, RA, Harris, LW: Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure. Fundam Appl Toxicol 1990; 15: 814–819.
36.Walday, P, Aas, P, Haider, T, Fonnum, F: Effect of pyridostigmine pre-treatment, HI-6 and toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure. Arch To xicol 1993; 67: 212–219.
37.Wetherell, J: Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapaci-tation produced by soman poisoning. J Pharm Pharmacol 1994; 46: 1023–1028.
38.Kim, Y-B, Shin, S, Sok, D-E, Kang, J-K: Effectiveness of procyclidine in combination with carbamate prophylactics against diisopropylfluorophosphate. Environ Toxicol Pharmacol 1998; 5: 43–49.
39.Philippens, IHCHM, Melchers, BPC, Olivier, B, Bruijnzeel, PLB: Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol Biochem Behaviour 2000; 65(1): 175–182.
40.Meshulam, Y, Davidovici, R, Wengier, A, Levy, A: Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs. J Appl Toxicol 1995; 15: 4: 263–266.
41.Lallement, G, Baille, V, Baubichon, D, Carpentier, P, Collombet, J-M, Filliat, P, Foquin, A, Four, E, Masqueliez, C, Testylier, G, Tonduli, L, Dorandeu, F: Review of the value of huperzine as pre-treatment of organophosphate poisoning. Neurotoxicol 2002; 23: 1–5.
42.Weinstock, M: Selectivity of cholinesterase inhibition. CNS Drugs 1999; 12: 4: 307–323.
43.Lahiri, DK, Farlow, MR, Greig, NH, Sambamurti, K: Current drug targets for Alzheimer's disease treatment. Drug Development Res 2002; 56: 267–281.
44.McDonough, JH, Jaax, NK, Crowley, RA, Mays, MZ, Modrow, HE: Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fund Appl Toxicol 1989; 13: 256–276.
45.Capacio, BR, Shih, T-M: Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 1991; 32: 604–615.
46.Shih, T-M, Koviak, TA, Capacio, BR: Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms. Neurosci Biobehav Rev 1991; 15: 349–362.
47.Shih, T-M, McDonough, JH, Koplovitz, I: Anticonvulsants for soman-induced seizure activity. J Biomed Sci 1999; 6: 86–96.
48.Kim, Y-B, Cheon, K-C, Hur, G-H, Phi, T-S, Choi, S-J, Hong, D, Kang, J-K: Effects of combinational prophylactics composed of physostigmine and pro-cyclidine on soman-induced lethality, seizures and brain injuries. Envir To xicol Pharmacol 2002; 11: 15–21.
49.Myhrer, T, Skymoen, LR, Aas, P: Pharmacological agents, hippocampal EEG and anticonvulsant effects on soman-induced seizures in rats. Neurotoxicol 2003 (in press).
50.Sparenborg, S, Brennecke, LH, Jaax, NK, Braitman, DJ: Dizocilpine (MK-801) arrests status-epilepticus and prevents brain-damage induced by soman. Neuropharm 1992; 31: 4: 357–368.
51.Carpentier, P, Foquin-Tarricone, A, Bodjarian, N, Rondouin, G, Lerner-Natoli, M, Kamenka, JM, Blanchet, G, Denoyer, M, Lallement, G: Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicol 1994; 15: 4: 837–852.
52.Lallement, G, Pernot-Marino, I, Baubichon, D, Burckhart, MF, Carpentier, P, Blanchet, G: Modulation of soman-induced neuropathology with an anti-convulsant regimen. NeuroReport 1994; 5: 2265–2268.
53.Solberg, Y, Belkin, M: The role of excitotoxicity in organophosphorus nerve agents central poisoning. Trends Pharmacol Sci 1997; 18: 183–185.
54.Phillis, JW: Adenosine in the control of the cerebral circulation. Cerebrovascular and Brain Metabolism Rev 1989; 1: 26–54.
55.Rudolphi, K, Schubert, P, Parkinson, FE, Fredholm, BB: Neuroprotective role of adenosine in cerebral ischaemia. Trends in Pharmacol Sci 1992; 13: 439–445.
56.Aas, P, Fonnum, F: Presynaptic inhibition of acetylcholine release. Acta Physiol Scand 1982; 127: 335–342.
57.Van Helden, HPM, Beuters, TJH: Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning. Trends Pharmacol. Sci 1999; 20: 438–441.
58.Aas, P, Fonnum, F: The effect of soman on potassium evoked 3H-acetyl-choline release in the isolated rat bronchi. Pharmacol and Toxicol 1987; 60: 206–209.
59.Aas, P, Maclagan, J: Evidence for prejunctional M2 muscarinic receptors in pulmonary cholinergic nerves in the rat. Br J Pharmacol 1990; 101: 73–76.
60.Junien, JL, Leonard, BE: Drugs acting on sigma and phencyclidine receptors: A review of their nature, function and possible therapeutic importance. Clin Neuropharmacol 1989; 12: 353–374.
61.Lallement, G, Delmanche, IS, Pernot-Marino, I, Baubichon, D, Denoyer, M, Carpentier, P, Blanchet, G: Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: Quantification with a w3 site ligand. Brain Res 1993; 618: 227–237.
62.Dematteis, M, Mallaret, M, Baubichon, D, Pernot-Marino, I, Lallement, G: Evaluation of dextromethorphan and dextrorphan as preventive treatment of soman toxicity in mice. Neurosci Lett 1997; 234: 91–94.
63.Dretchen, KL, Bowles, AM, Raines, A: Protection by phenytoin and calcium channel blocking agents against the toxicity of diisopropylfluorophosphate. To xicol Appl Pharmacol 1986; 83: 584–589.
64.Sterri, SH, Lyngaas, S, Fonnum, F: Toxicity of soman after repetitive injection of sublethal doses in guinea-pig and mouse. Acta Pharm et Toxicol 1991; 49: 8–13.
65.Wolfe, AD, Rush, RS, Doctor, BP, Koplovitz, I, Jones, D: Acetylcholinesterase prophylaxis against organophosphate toxicity. Fund ApplToxicol 1987; 9: 266–270.
66.Doctor, BP, Maxwell, DM, Ashani, Y, Saxena, A, Gordon, RK: New approaches to medical protection against chemical warfare nerve agents. In: Chemical Wa r fare Agents: Toxicity at Low Levels. Somani, SM, Romano, JA (eds), 2001. pp 191–214.
67.Filbert, MG, Forster, JS, Smith, CD, Ballough, GPH: Neuroprotective effects of HU-211 on brain damage resulting from soman-induced seizures. Ann NY Acad Sci 1999; 890: 505–514.
68.Bouchaud, C, Chollat-Namy, A, Duserre, S, Delamanche, IS: The role of nitric oxide in the neuropathology in soman intoxication. Brain Res 1994; 660: 249–254.
69.Jacobsson, SOP, Cassel, G, Persson, SÅ: Increased levels of nitrogen oxides and lipid peroxidation in the rat brain after soman-induced seizures. Arch To xicol 1999; 73: 269–273.
70.Svensson, I, Waara, L, Johansson, L, Bucht, A, Cassel, G: Soman-induced interleukin-1 beta mRNA and protein in rat brain. Neurotoxicol 2001; 22: 3: 355–362.
71. Review of acute human-toxicity estimates for selected chemical-warfare agents. Washington DC: National Academy Press, 1997.